BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35506577)

  • 1. Improving donor retention following a temporary deferral: A cluster randomized controlled trial of deferral educational materials.
    Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Karki S; Davison TE
    Transfusion; 2022 Jun; 62(6):1230-1239. PubMed ID: 35506577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Educating donors about deferrals through the provision of tailored materials: Findings from a survey of deferred donors.
    Gemelli CN; Kruse SP; Thijsen A; Van Dyke N; Davison TE
    Transfusion; 2021 Mar; 61(3):822-829. PubMed ID: 33615506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notifying donors when their deferral is ending: An effective donor retention strategy.
    Gemelli CN; Thijsen A; Van Dyke N; Kruse SP; Davison TE
    Transfusion; 2021 Oct; 61(10):2930-2940. PubMed ID: 34352927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of temporary deferrals on future blood donation behavior across the donor life cycle.
    Clement M; Shehu E; Chandler T
    Transfusion; 2021 Jun; 61(6):1799-1808. PubMed ID: 33780022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do deferred donors continue their donations? A large-scale register study on whole blood donor return in the Netherlands.
    Spekman MLC; van Tilburg TG; Merz EM
    Transfusion; 2019 Dec; 59(12):3657-3665. PubMed ID: 31621923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of iron education through a mobile application on donor return after deferral for low hemoglobin.
    Hasan MI; Noordin SS; Hami R; Ishak N; Achuthan A
    Blood Transfus; 2022 Nov; 20(6):446-453. PubMed ID: 35848625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of efforts to maintain safe donor in main donor pool after completion of temporary deferral period.
    Shah R; Tulsiani S; Harimoorthy V; Mathur A; Choudhury N
    Asian J Transfus Sci; 2013 Jan; 7(1):63-7. PubMed ID: 23559769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of post-donation communication materials to increase donor return following a vasovagal reaction.
    Thijsen A; Gemelli CN; Davison TE; Masser B
    Transfusion; 2023 Sep; 63(9):1701-1709. PubMed ID: 37493388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and causes of pre-donation deferrals at a Chinese blood center.
    Yang Y
    Transfus Apher Sci; 2021 Aug; 60(4):103153. PubMed ID: 34016553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons.
    Al Shaer L; Sharma R; AbdulRahman M
    J Blood Med; 2017; 8():55-60. PubMed ID: 28579846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor return after temporary deferral.
    Custer B; Schlumpf KS; Wright D; Simon TL; Wilkinson S; Ness PM;
    Transfusion; 2011 Jun; 51(6):1188-96. PubMed ID: 21155833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors.
    Smith GA; Fisher SA; Doree C; Di Angelantonio E; Roberts DJ
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009532. PubMed ID: 24990381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of motivations for return donation among deferred blood donors. American Red Cross ARCNET Study Group.
    Munsterman KA; Grindon AJ; Sullivan MT; Trouern-Trend J; Blackmon MJ; Watkins J; Williams AE
    Transfusion; 1998 Jan; 38(1):45-50. PubMed ID: 9482393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin measurement IN Donors-Effectiveness of iron Monitoring to diminish iron deficiency and low haemoglobin in whole blood donors (FIND'EM): study protocol for a stepped wedge cluster randomised trial.
    Sweegers MG; Zalpuri S; Quee FA; Huis In 't Veld EMJ; Prinsze FJ; Hoogendijk EO; Twisk JWR; van Weert AWM; de Kort WLAM; van den Hurk K
    Trials; 2020 Oct; 21(1):823. PubMed ID: 32998766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood donor return rates after deferral for tattooing or body piercing-Survey across blood donation services: The BEST collaborative study.
    Quee F; O'Brien SF; Prinsze F; Steele WR; Grégoire Y; Cutajar A; Wendel S; Compernolle V; Goldman M; van den Hurk K;
    Vox Sang; 2022 Sep; 117(9):1085-1089. PubMed ID: 35706056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
    Spekman MLC; Ramondt S; Sweegers MG
    Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stigmatizing deferrals disproportionally reduce donor return rates: Evidence from Brazil.
    Vieites Y; Ferreira CM; Goldszmidt R; Andrade EB
    Vox Sang; 2024 Jun; 119(6):606-611. PubMed ID: 38425028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole blood donor deferral analysis at a center in Western India.
    Agnihotri N
    Asian J Transfus Sci; 2010 Jul; 4(2):116-22. PubMed ID: 20859512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the Mood for a Blood Donation? Pilot Study about Momentary Mood, Satisfaction, and Return Behavior in Deferred First-Time Donors.
    Greffin K; Muehlan H; Tomczyk S; Suemnig A; Schmidt S; Greinacher A
    Transfus Med Hemother; 2021 Aug; 48(4):220-227. PubMed ID: 34539315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.